These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


159 related items for PubMed ID: 2079377

  • 1. [Pharmacokinetics of cefixime in volunteers and a literature comparison with the new ester prodrug cephalosporins].
    Kees F, Naber KG.
    Infection; 1990; 18 Suppl 3():S150-4. PubMed ID: 2079377
    [Abstract] [Full Text] [Related]

  • 2. Relative bioavailability of three cefixime formulations.
    Kees F, Naber KG, Sigl G, Ungethüm W, Grobecker H.
    Arzneimittelforschung; 1990 Mar; 40(3):293-7. PubMed ID: 2346538
    [Abstract] [Full Text] [Related]

  • 3. Comparative pharmacokinetics of oral ceftibuten, cefixime, cefaclor, and cefuroxime axetil in healthy volunteers.
    Nix DE, Symonds WT, Hyatt JM, Wilton JH, Teal MA, Reidenberg P, Affrime MB.
    Pharmacotherapy; 1997 Mar; 17(1):121-5. PubMed ID: 9017772
    [Abstract] [Full Text] [Related]

  • 4. Comparative bioavailability study of cefixime administered as tablets or aqueous solution.
    Montay G, Masala F, Le Roux Y, Le Liboux A, Uhlrich J, Chassard D, Thebault JJ, Roche G, Frydman A.
    Drugs; 1991 Mar; 42 Suppl 4():6-9. PubMed ID: 1725153
    [Abstract] [Full Text] [Related]

  • 5. Cefetamet pivoxil clinical pharmacokinetics.
    Blouin RA, Stoeckel K.
    Clin Pharmacokinet; 1993 Sep; 25(3):172-88. PubMed ID: 8222459
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Pharmacokinetics of cefixime after oral and intravenous doses in dogs: bioavailability assessment for a drug showing nonlinear serum protein binding.
    Bialer M, Wu WH, Look ZM, Silber BM, Yacobi A.
    Res Commun Chem Pathol Pharmacol; 1987 Apr; 56(1):21-32. PubMed ID: 3589152
    [Abstract] [Full Text] [Related]

  • 11. The pharmacokinetics of the oral cephalosporins--a review.
    Wise R.
    J Antimicrob Chemother; 1990 Dec; 26 Suppl E():13-20. PubMed ID: 2292525
    [Abstract] [Full Text] [Related]

  • 12. Pharmacokinetics of new oral cephalosporins, including a new carbacephem.
    Fassbender M, Lode H, Schaberg T, Borner K, Koeppe P.
    Clin Infect Dis; 1993 May; 16(5):646-53. PubMed ID: 8507756
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Pharmacokinetic profile of cefixime in man.
    Faulkner RD, Yacobi A, Barone JS, Kaplan SA, Silber BM.
    Pediatr Infect Dis J; 1987 Oct; 6(10):963-70. PubMed ID: 3696837
    [Abstract] [Full Text] [Related]

  • 16. In vitro activity and cross resistance studies with cefpodoxime.
    Grimm H.
    Zentralbl Bakteriol; 1991 Dec; 276(1):54-62. PubMed ID: 1789901
    [Abstract] [Full Text] [Related]

  • 17. Pharmacokinetics and cerebrospinal fluid concentrations of cefixime in infants and young children.
    Nahata MC, Kohlbrenner VM, Barson WJ.
    Chemotherapy; 1993 Dec; 39(1):1-5. PubMed ID: 8444056
    [Abstract] [Full Text] [Related]

  • 18. Pharmacokinetics and bioavailability of oral cephalosporins, KR-984055 and its prodrugs, KR-999001 and KR-999002, in the rat.
    Park YS, Woo SK, Jung MH, Kwon KI.
    Arch Pharm Res; 2003 Jan; 26(1):83-8. PubMed ID: 12568364
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.